United States:
CEOS And CFOS Make Difficult Decisions As Hospitals Under Strain (Video)
16 February 2023
Sheppard Mullin Richter & Hampton
To print this article, all you need is to be registered or login on Mondaq.com.
Nioura Ghazni, a partner in the corporate practice group of
Sheppard Mullin's San Francisco office, says that hospital
leaders have to focus on streamlining mission and operations,
adding revenue streams, and avoiding regulatory risk.
Previously published in Healthcare Finance
The content of this article is intended to provide a general
guide to the subject matter. Specialist advice should be sought
about your specific circumstances.
POPULAR ARTICLES ON: Food, Drugs, Healthcare, Life Sciences from United States
FDA Ramps Up Actions On PFAS
Holland & Knight
The U.S. Food and Drug Administration (FDA) has increased regulatory activity with regard to per- and polyfluoroalkyl substances (PFAS).